电邮这篇文章 PROSPEKTIVNAYa OTsENKA DINAMIKI PLOShchADI ChERNOY SUBSTANTsII PO DANNYM TRANSKRANIAL'NOY SONOGRAFII U BOL'NYKh S BOLEZN'Yu PARKINSONA
- 作者: Chechetkin AO1, Fedotova EY.1, Kravchenko MA1, Illarioshkin SN1
-
隶属关系:
- Научный центр неврологии
- 期: 卷 38, 编号 3 (Прил) (2019)
- 页面: 165-166
- 栏目: Articles
- URL: https://journals.rcsi.science/RMMArep/article/view/26171
- DOI: https://doi.org/10.17816/rmmar26171
- ID: 26171
如何引用文章
全文:
详细
作者简介
A Chechetkin
Научный центр неврологииМосква
E Fedotova
Научный центр неврологииМосква
M Kravchenko
Научный центр неврологииМосква
S Illarioshkin
Научный центр неврологииМосква
参考
- Becker, G. Degeneration of substantia nigra in chronic Parkinson’s disease visualized by transcranial color-coded real-time sonography / Becker G., Seufert J., Bogdahn U. et al. // Neurology. - 1995. - V.45. - P.182-184.
- Berg, D. Disturbance of iron metabolism as a contributing factor to SN hyperechogenicity in Parkinson’s disease: Implications for idiopathic and monogenetic forms / Berg D. // Neurochem. Res. - 2007. - V.32. - P.1646-1654.
- Stankiewicz, J. Iron in chronic brain disorders: Imaging and neurotherapeutic implications / Stankiewicz J., Panter S.S., Neema M. et al. // Neurotherapeutics. - 2007. - V.4. - N3. - P.371-386.
- Prestel, J. Predictive value of transcranial sonography in the diagnosis of Parkinson’s disease / Prestel J., Schweitzer K.J., Hofer A. et al. // Mov. Disord. - 2006. - V.21. - P.1763-1765.
- Berardelli, A. EFNS/MDS-ES recommendations for the diagnosis of Parkinson’s disease / Berardelli A., Wenning G.K., Antonini A. et al. // Eur. J. Neurol. - 2013. - V.20. N.1. - P.16-34.
- Федотова, е.Ю. Транскраниальная сонография при болезни Паркинсона / Федотова е.Ю., Чечёткин А.О., Шадрина М.И. и др. // Журн. неврол. и психиатр. - 2011. - №11. - С. 49-55.
- Behnke, S. Long-term course of substantia nigra hyperechogenicity in Parkinson’s disease / Behnke S., Runkel A., Kassar H.A. et al. // Mov. Disord. - 2013. - V.28. - N.4. - P.455-459.
- Berg, D. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson’s disease / Berg D., Merz B., Reiners K. et al. // Mov. Disord. - 2005. - V.20. - N.3. - P.383-385.
- Iranzo, A. Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder / Iranzo A., Stockner H., Serradell M. et al. // Mov. Disord. - 2014. -V.29. - N.14. - P.1774-1780.
- Mahlknecht, P. Substantia nigra hyperechogenicity as a marker for Parkinson’s disease: a population-based study / Mahlknecht P., Seppi K., Stockner H. et al. // Neurodegener. Dis. - 2013. - V.12. - N.4. - P.212-218.
补充文件
